Literature DB >> 10642242

Using cost effectiveness information.

A Briggs1, A Gray.   

Abstract

Mesh：

Year:  2000        PMID： 10642242      PMCID： PMC1117441          DOI： 10.1136/bmj.320.7229.246

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Economic Notes: opportunity cost.

Authors:  S Palmer; J Raftery
Journal:  BMJ       Date:  1999-06-05

2.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Authors:  A Laupacis; D Feeny; A S Detsky; P X Tugwell
Journal:  CMAJ       Date:  1992-02-15       Impact factor: 8.262

3.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

4.  Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.

Authors:  A Gafni; S Birch
Journal:  CMAJ       Date:  1993-03-15       Impact factor: 8.262

Review 5.  QALY league tables: handle with care.

Authors:  K Gerard; G Mooney
Journal:  Health Econ       Date:  1993-04       Impact factor: 3.046

6.  Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.

Authors:  P D Pharoah; W Hollingworth
Journal:  BMJ       Date:  1996-06-08
  6 in total
  10 in total

1.  An introduction to economic evaluation.

Authors:  S Goodacre; C McCabe
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

2.  Cost-effectiveness league tables: valuable guidance for decision makers?

Authors:  Josephine Mauskopf; Frans Rutten; Warren Schonfeld
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  Knowing we practise good medicine: implementing the electronic medical record in family practice.

Authors:  Martin Dawes; David Chan
Journal:  Can Fam Physician       Date:  2010-01       Impact factor: 3.275

Review 4.  Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and Finland.

Authors:  Javier C Angulo; Antti Valpas; Javier Rejas; Kari Linden; Marion Kvasz; Sonya J Snedecor
Journal:  Clin Drug Investig       Date:  2014-05       Impact factor: 2.859

Review 5.  Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness.

Authors:  Michael Schlander
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 4.785

Review 6.  Mirtazapine. A pharmacoeconomic review of its use in depression.

Authors:  K J Holm; B Jarvis; R H Foster
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 7.  Is surgical repair of an asymptomatic groin hernia appropriate? A review.

Authors:  B van den Heuvel; B J Dwars; D R Klassen; H J Bonjer
Journal:  Hernia       Date:  2011-02-05       Impact factor: 4.739

8.  Economic evaluation of surgical insertion of ventilation tubes for the management of persistent bilateral otitis media with effusion in children.

Authors:  Syed Mohiuddin; Anne Schilder; Iain Bruce
Journal:  BMC Health Serv Res       Date:  2014-06-13       Impact factor: 2.655

9.  Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.

Authors:  Ulrike Kuchenbecker; Daniela Chase; Anika Reichert; Julia Schiffner-Rohe; Mark Atwood
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

10.  Total Hip Arthroplasty When Utilised in Young Adults Is a Cost-Effective Procedure: A 10-Year and Lifetime Cost-Utility Analysis.

Authors:  Paul H C Stirling; Navnit S Makaram; Nick D Clement; Deborah Macdonald; Gavin J Macpherson
Journal:  Cureus       Date:  2022-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.